These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 198969)

  • 1. [Differences in the antiviral and antioncogenic action of interferons produced in murine peritoneal cells and in Krebs-2 ascitic carcinoma cells].
    Marchenko VI; Pokidysheva LN; Malinovskaia VV; Aliab'eva TI; Khesin IaE
    Vopr Virusol; 1977; (3):344-8. PubMed ID: 198969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological and histochemical studies on cultures of mouse peritoneal leucocytes during interferon formation.
    Khesin YE; Voronina FV; Amchenkova AM
    Acta Virol; 1970 Nov; 14(6):445-52. PubMed ID: 4099770
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reasons for lowered resistance to Krebs 2 ascitic carcinoma in mice in a state of hyporeactivity (tolerance) to a viral interferon inducer].
    Marchenko VI; Pokidysheva LN; Zubanova NA; Voronina FV
    Vopr Virusol; 1976; (2):176-9. PubMed ID: 936575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cryomethod of concentrating interferon (author's transl)].
    Marchenko VI; Pokidysheva LN; Orlova NG
    Vopr Virusol; 1975; (5):568-70. PubMed ID: 174324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of a number of antitumor preparations on RNA- and protein-synthesizing processes and viral interferon induction in Krebs 2 ascites carcinoma cells].
    Shloma DV; Krispin TI; Balandin IG
    Vopr Virusol; 1982; 27(6):735-8. PubMed ID: 6186093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different antiviral activity and cell specificity of interferon preparations produced by mouse peritoneal cells at 37 degrees C and at 26 degrees C.
    Cembrzyńska-Nowak M
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):499-502. PubMed ID: 2484831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of spontaneous interferon by mouse peritoneal cells in vitro. I. Attempts to elucidate the origin of spontaneous interferon.
    Blach-Olszewska Z; Cembrzýńska-Nowak M
    Acta Biol Med Ger; 1979; 38(5-6):765-73. PubMed ID: 230673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitor of the action of swine leukocyte interferon].
    Parfenov VV; Timofeev IV; Zubanova NA
    Vopr Virusol; 1982; 27(3):338-41. PubMed ID: 6181615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Concentration of heterogeneous leukocyte interferon].
    Solov'ev VD; Parfenov VV; Zubanova NA; Pokidysheva LN; Tkach TA
    Vopr Virusol; 1981; (6):720-4. PubMed ID: 6175114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of age-related serum factors in the mechanism of interferon production].
    Malinovskaia VV; Pokidysheva LN; Balakireva NN
    Vopr Virusol; 1980; (3):298-303. PubMed ID: 6159732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stimulation of the inhibiting effect of interferon on the growth of ascitic carcinoma in relation to host responsiveness and cells].
    Pokidysheva LN; Voronina FV; Khesin IaE; Marchenko VI
    Vopr Virusol; 1976; (5):591-6. PubMed ID: 1007229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.
    Youngner JS; Salvin SB
    J Immunol; 1973 Dec; 111(6):1914-22. PubMed ID: 4356326
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of different biological response modifiers on interferon expression in bacterial lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive mouse peritoneal macrophages.
    Di Marzio P; Gessani S; Locardi C; Borghi P; Baglioni C; Belardelli F
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2585-91. PubMed ID: 1701475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiviral activity of murine interferons produced by bacterial and animal cell translation of messenger RNA].
    Mamontova TV; Mentkevich LM; Orlova TG
    Vopr Virusol; 1980; (1):63-7. PubMed ID: 6158177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
    Maheshwari RK; Friedman RM
    J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP potentiation of interferon antiviral activity and effect of interferon on cellular cyclic AMP levels.
    Weber JM; Stewart RB
    J Gen Virol; 1975 Sep; 28(3):363-72. PubMed ID: 170377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus.
    Wagner RR; Huang AS
    Virology; 1966 Jan; 28(1):1-10. PubMed ID: 4159265
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of the antiviral and antiproliferative activity of human interferon preparations obtained in suspension and stationary cultures of donor leukocytes].
    Timofeev IV; Kuznetsov VP; Mekhedov LN; Nikolaeva TG; Orlova TG
    Antibiotiki; 1981 Sep; 26(9):703-5. PubMed ID: 6170254
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of serum of different origin on elaboration of interferon and the activity of the lysosomal apparatus of cells from the abdominal exudate of newborn mice].
    Malinovskaia VV; Khesin IaE; Pokidysheva LN
    Vopr Virusol; 1978; (3):346-50. PubMed ID: 695523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on the anticellular and antiviral effects of interferon and the haemopoietic stem cell inhibition factor.
    Orlova TG; Golovanova TA; Shcheglovitova ON; Mysyakin EB; Bokhonko AI; Kaulen DR
    Acta Virol; 1979 May; 23(3):177-82. PubMed ID: 41429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.